Clobazam Suspension
Product Images NDC 51672-4227

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 51672-4227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clobazam 01)

Chemical structure of clobazam, the active ingredient in the Clobazam 2.5 mg/mL oral suspension by Sun Pharmaceutical Industries, Inc. The diagram shows its molecular framework including chlorine, methyl, and phenyl substituents on a diazepine ring.*

FDA Label Image

Figure 1 (Clobazam 02)

A bar chart illustrating the percentage reduction in weekly drop seizure rate across four groups: Placebo, Low, Medium, and High. The chart shows increasing reduction percentages from placebo to high, with numerical values labeled on each bar and respective sample sizes noted below each group category.*

FDA Label Image

Figure 2 (Clobazam 03)

A bar chart showing the proportion of patients (%) across different ranges of reduction in weekly drop seizure frequency from baseline (%). Four groups are compared: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High dose. The x-axis categorizes reductions from 'Worse' to '80 to 100%', and the y-axis represents patient proportions from 0 to 70%. The chart illustrates treatment response distribution among these groups.*

FDA Label Image

Figure A (Clobazam 04)

Clobazam Oral Suspension 2.5 mg/mL in a white bottle with a bottle adapter and two oral syringes. The packaging and bottle are labeled with the product name, strength, and indicate oral administration. The labeler is Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Figure B (Clobazam 05)

An instructional image showing a hand holding a white bottle of Clobazam oral suspension, 2.5 mg/mL, manufactured by Sun Pharmaceutical Industries, Inc. The image includes a graphic arrow with text indicating to 'Shake well' before use.*

FDA Label Image

Figure C (Clobazam 06)

An instructional diagram showing a close-up of a hand placing a child-resistant cap onto a white oral suspension bottle. The downward arrow indicates the direction to push the cap for closure.*

FDA Label Image

Figure D (Clobazam 07)

An instructional diagram of an oral dosing syringe. The diagram labels four parts: Tip, Dosage indicators, Barrel, and Plunger, illustrating components used for measuring and administering liquid medication orally.*

FDA Label Image

Figure E (Clobazam 08)

An instructional image showing a hand holding a dosing syringe for oral suspension medication administration, inserting it vertically into the neck of a bottle. The image emphasizes the correct placement of the syringe for drawing medication from the bottle.*

FDA Label Image

Figure F (Clobazam 09)

An instructional illustration showing a syringe drawing liquid medication from a bottle, with a downward arrow indicating the direction for drawing the suspension. The syringe markings are visible, and the image depicts oral dosing preparation for Clobazam 2.5 mg/mL oral suspension.*

FDA Label Image

Figure G (Clobazam 10)

An instructional illustration showing a syringe used for measuring oral suspension medication. The image emphasizes measuring the dose at the top of the red plunger, with an arrow pointing to this specific area. The syringe is connected to a white bottle nozzle at the top.*

FDA Label Image

Figure H (Clobazam 11)

Black and white instructional image showing a young girl receiving oral liquid medication through a syringe held by an adult hand, demonstrating proper administration technique for a suspension oral dosage form.*

FDA Label Image

Figure I (Clobazam 12)

Illustration demonstrating how to open the cap of a Clobazam oral suspension bottle by twisting the child-resistant cap in the direction indicated by the arrows. The bottle label partially shows the product name Clobazam Oral Suspension and NDC 51672-4227-8.*

FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

Box label for Clobazam Oral Suspension 2.5 mg/mL in a 120 mL bottle. The label shows the drug name, strength, dosage form, and volume. It includes directions stating "FOR ORAL ADMINISTRATION ONLY" and advises dispensing the enclosed medication guide. The labeler is Sun Pharmaceutical Industries, Inc., with manufacturing by Taro Pharmaceutical Industries Ltd. The packaging includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.